Overview

A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

Status:
Terminated
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
This is a A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
Phase:
Early Phase 1
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborator:
Memorial Sloan Kettering Cancer Center
Treatments:
Ribavirin